K. Lagos

发表

Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia.

H. Milionis, M. Kostapanos, M. Elisaf, 2008, European journal of pharmacology.

Improvement of the Lipid Profile with Zofenopril in Hypertensive Patients with the Metabolic Syndrome

M. Kostapanos, M. Elisaf, A. Tselepis, 2008 .

mprovement of the Lipid Profile with Zofenopril in Hypertensive Patients with the Metabolic Syndrome

M. Kostapanos, M. Elisaf, A. Tselepis, 2008 .

Increased plasma visfatin levels in subjects with the metabolic syndrome

M. Elisaf, T. Filippatos, I. Gazi, 2007, European journal of clinical investigation.

Alterations in the High Density Lipoprotein Phenotype and HDL-Associated Enzymes in Subjects with Metabolic Syndrome

M. Elisaf, T. Filippatos, D. Mikhailidis, 2008, Lipids.

Acute infection with Epstein-Barr virus is associated with atherogenic lipid changes.

E. Liberopoulos, M. Elisaf, I. Gazi, 2010, Atherosclerosis.

Dose-Dependent Effect of Rosuvastatin Treatment on Urinary Protein Excretion

H. Milionis, M. Kostapanos, M. Elisaf, 2007, Journal of cardiovascular pharmacology and therapeutics.

The relationship of vitamin D with non-traditional risk factors for cardiovascular disease in subjects with metabolic syndrome

E. Liberopoulos, M. Elisaf, M. Florentin, 2012, Archives of medical science : AMS.

Epigenetics in diagnosis, prognostic assessment and treatment of cancer: an update

T. Crook, E. Hatzimichael, Van Ren Sim, 2014, EXCLI journal.

Revisiting bleomycin from pathophysiology to safe clinical use.

E. Hatzimichael, D. Daliani, C. Papandreou, 2013, Critical reviews in oncology/hematology.

Differences in metabolic parameters and cardiovascular risk between American Diabetes Association and World Health Organization definition of impaired fasting glucose in European Caucasian subjects: a cross-sectional study

M. Elisaf, T. Filippatos, D. Mikhailidis, 2013, Archives of medical science : AMS.

Durable response to lenalidomide in a patient with myelodysplastic syndrome associated with isolated 5q deletion and JAK2 V617F mutation despite discontinuation of treatment.

E. Hatzimichael, A. Vassou, Dora Gougopoulou, 2016, Molecular and clinical oncology.

Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia.

H. Milionis, M. Kostapanos, M. Elisaf, 2008, European journal of pharmacology.